Theratechnologies Announces Completion of Acquisition by Future Pak.
Click here to learn more.
We currently market prescription products for people with HIV in the United States.
Theratechnologies is a biopharmaceutical company focused on the development and commercialization of innovative therapies.
We currently market prescription products for people with HIV in the United States.
Theratechnologies develops and commercializes innovative therapies. The Company currently commercializes two products in the field of HIV. Trogarzo® and EGRIFTA SV®/WR™ are approved in the United States.